Author(s): S. Janani1, P. Geetha, P. Shanmugasundaram

Email(s): lgeethapharma@gmail.com

DOI: 10.5958/0974-360X.2017.00071.3   

Address: S. Janani1, P. Geetha*, P. Shanmugasundaram
School of Pharmaceutical Sciences, Vels University (VISTAS), Velan Nagar, P.V. Vaithiyalingam Road, Pallavaram, Chennai- 600 117. Tamil Nadu, India.
Corresponding author

Published In:   Volume - 10,      Issue - 1,     Year - 2017


ABSTRACT:
Epilepsy is one of the neurological disorder characterised by a period of epileptic seizures. The findings reveal that type 1 diabetes may increase epilepsy risk three fold. About 25% to 45% of epilepsy cases can be due to structural modifications, metabolic disorders, and genetic characters but early research has also claimed that diabetes might explain some idiopathic seizures, Dr Chou and their colleagues wrote. Those people with type 1 diabetes but without hypoglycaemia found to have a 2.67 fold increased risk of developing epilepsy during medication vs. the other group, whereas those with both type 1 diabetes and hypoglycaemia might have about 16.5 fold increased risk of developing epilepsy.


Cite this article:
S. Janani1, P. Geetha, P. Shanmugasundaram. Diabetes-Epilepsy Symbiosis. Research J. Pharm. and Tech. 2017; 10(1): 351-354. doi: 10.5958/0974-360X.2017.00071.3

Cite(Electronic):
S. Janani1, P. Geetha, P. Shanmugasundaram. Diabetes-Epilepsy Symbiosis. Research J. Pharm. and Tech. 2017; 10(1): 351-354. doi: 10.5958/0974-360X.2017.00071.3   Available on: https://rjptonline.org/AbstractView.aspx?PID=2017-10-1-71


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available